Cargando…
Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine
Genetic cardiomyopathies have been studied for decades, and it has become increasingly clear that these progressive diseases are more complex than originally thought. These complexities can be seen both in the molecular etiologies of these disorders and in the clinical phenotypes observed in patient...
Autores principales: | Greenberg, Michael J., Tardiff, Jil C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852459/ https://www.ncbi.nlm.nih.gov/pubmed/33512404 http://dx.doi.org/10.1085/jgp.202012662 |
Ejemplares similares
-
Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure
por: Day, Sharlene M., et al.
Publicado: (2022) -
Sex‐Related Differences in Genetic Cardiomyopathies
por: Argirò, Alessia, et al.
Publicado: (2022) -
Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics
por: Keyt, Lucas K., et al.
Publicado: (2022) -
State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy
por: Patel, Viraj, et al.
Publicado: (2020) -
Divergent Molecular Phenotypes in Point Mutations at the Same Residue in Beta-Myosin Heavy Chain Lead to Distinct Cardiomyopathies
por: Lehman, Sarah J., et al.
Publicado: (2023)